Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04128072 |
|---|---|
| Brief Title: | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma (MOGAT) |
| First Submitted : | October 14, 2019 |
| First Submitted that Met QC Criteria : | October 14, 2019 |
| First Posted : | October 16, 2019 |
| Last Update Submitted that Met QC Criteria : | April 4, 2024 |
| Last Update Posted : | April 5, 2024 |